Hanhart syndrome
Hanhart syndrome | |
Hanhart syndrome | |
DiseasesDB | 13486 |
---|
WikiDoc Resources for Hanhart syndrome |
Articles |
---|
Most recent articles on Hanhart syndrome Most cited articles on Hanhart syndrome |
Media |
Powerpoint slides on Hanhart syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Hanhart syndrome at Clinical Trials.gov Trial results on Hanhart syndrome Clinical Trials on Hanhart syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Hanhart syndrome NICE Guidance on Hanhart syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Hanhart syndrome Discussion groups on Hanhart syndrome Patient Handouts on Hanhart syndrome Directions to Hospitals Treating Hanhart syndrome Risk calculators and risk factors for Hanhart syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for Hanhart syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Richner-Hanhart syndrome; tyrosinaemia type 2; tyrosine aminotransferase deficiency; palmoplantar ectodermal dysplasia type 5
Overview
Richner Hanhart Syndrome, also called Richner Syndrome and Hanhart Syndrome, is a rare autosomal recessive disorder due to a deficiency in enzyme tyrosine amino transferase. It is named for Ernst Hanhart and Hermann Richner, who independently reported it in 1947 and 1938, respectively.
Pathophysiology
Genetics
Richner Hanhart Syndrome occurs from a deficiency of the enzyme tyrosine amino transferase (TAT). TAT is located on chromosome 16q22.1-q 22.3.[1]
Diagnosis
Symptoms
Symptoms of Richner Hanhart Syndrome include ocular lesions and palmo-plantar hyperkeratosis. Eye symptoms develop from two weeks of age and include redness, lacrimation and photophobia. Tyrosine crystals in the cornea cause corneal clouding with coneal opacities, corneal scarring and dendritic ulcers. In the first year of life, the patient will show skin conditions like nonpruritic hyperkeratotic papules and plaques on the palms and soles. Mental retardation affects less than 50% of all cases. Patients will have high levels of tyrosine in the urine.
Treatment
Dietary restriction of amino acids phenylalanine and tyrosine is an effective treatment for people with Richner Hanhart Syndrome.
References
- ↑ "medind.nic.in" (PDF). Retrieved 2012-08-14.